Nasus Pharma Ltd.
No trades
No trades
Compare with Nasus Pharma Ltd.
−0.33 USD
−1.70 M USD
0.00 USD
5.95 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Brendan P. O'Grady
Website
Headquarters
Tel Aviv
Founded
2019
IPO date
Aug 13, 2025
ISIN
IL0012181553
FIGI
BBG01W00P7X8
Identifiers
ISIN IL0012181553
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of NSRX is 3.53 USD — it hasn't changed in the past 24 hours. Watch Nasus Pharma Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Nasus Pharma Ltd. stocks are traded under the ticker NSRX.
NSRX stock has risen by 0.90% compared to the previous week, the month change is a 12.06% rise, over the last year Nasus Pharma Ltd. has showed a −55.99% decrease.
We've gathered analysts' opinions on Nasus Pharma Ltd. future price: according to them, NSRX price has a max estimate of 22.00 USD and a min estimate of 18.00 USD. Watch NSRX chart and read a more detailed Nasus Pharma Ltd. stock forecast: see what analysts think of Nasus Pharma Ltd. and suggest that you do with its stocks.
NSRX reached its all-time high on Aug 22, 2025 with the price of 9.99 USD, and its all-time low was 1.98 USD and was reached on Mar 31, 2026. View more price dynamics on NSRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NSRX stock is 6.87% volatile and has beta coefficient of 1.36. Track Nasus Pharma Ltd. stock price on the chart and check out the list of the most volatile stocks — is Nasus Pharma Ltd. there?
Today Nasus Pharma Ltd. has the market capitalization of 41.34 M, it has decreased by −5.56% over the last week.
Yes, you can track Nasus Pharma Ltd. financials in yearly and quarterly reports right on TradingView.
Nasus Pharma Ltd. is going to release the next earnings report on Mar 3, 2027. Keep track of upcoming events with our Earnings Calendar.
NSRX net income for the last half-year is −1.96 M USD, while the previous report showed −1.39 M USD of net income which accounts for 0.00% change. Track more Nasus Pharma Ltd. financial stats to get the full picture.
No, NSRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 20, 2026, the company has 7 employees. See our rating of the largest employees — is Nasus Pharma Ltd. on this list?
Like other stocks, NSRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nasus Pharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nasus Pharma Ltd. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nasus Pharma Ltd. stock shows the neutral signal. See more of Nasus Pharma Ltd. technicals for a more comprehensive analysis.